Login Register Cart 0
Generic placeholder image

Current Pharmaceutical Design

Editor-in-Chief

ISSN (Print): 1381-6128
ISSN (Online): 1873-4286

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Rosuvastatin Improves Endothelial Dysfunction in Diabetes by Normalizing Endoplasmic Reticulum Stress via Calpain-1 Inhibition

Author(s): Zhao Zhao, Xinpeng Wang, Meili Lu* and Yuxia Gao*

Volume 29, Issue 32, 2023

Published on: 20 October, 2023

Page: [2579 - 2590] Pages: 12

DOI: 10.2174/0113816128250494231016065438

Price: $65

Abstract

Background: Rosuvastatin contributes to the improvement of vascular complications in diabetes, but the protective mechanisms remain unclear. The aim of the present study was to investigate the effect and mechanism of rosuvastatin on endothelial dysfunction induced by diabetes.

Methods: Calpain-1 knockout (Capn1 EK684-/-) and C57BL/6 mice were intraperitoneally injected with STZ to induce type 1 diabetes. Human umbilical vein endothelial cells (HUVECs) were incubated with high glucose in this study. The function of isolated vascular rings, apoptosis, and endoplasmic reticulum stress (ERS) indicators were measured in this experiment.

Results: The results showed that rosuvastatin (5 mg/kg/d) and calpain-1 knockout improved impaired vasodilation in an endothelial-dependent manner, and this effect was abolished by an ERS inducer. Rosuvastatin administration inhibited calpain-1 activation and ERS induced by high glucose, as well as apoptosis and oxidative stress both in vivo and in vitro. In addition, an ERS inducer (tunicamycin) offset the beneficial effect of rosuvastatin on endothelial dysfunction and ERS, which was accompanied by increased calpain-1 expression. The ERS inhibitor showed a similar improvement in endothelial dysfunction with rosuvastatin but could not increase the improvement in endothelial function of rosuvastatin.

Conclusion: These results suggested that rosuvastatin improves endothelial dysfunction by suppressing calpain- 1 and normalizing ERS, subsequently decreasing apoptosis and oxidative stress.

« Previous Next »
[1]
Zachariah M, Maamoun H, Milano L, Rayman MP, Meira LB, Agouni A. Endoplasmic reticulum stress and oxidative stress drive endothelial dysfunction induced by high selenium. J Cell Physiol 2021; 236(6): 4348-59.
[http://dx.doi.org/10.1002/jcp.30175] [PMID: 33241572]
[2]
Leng B, Li C, Sun Y, et al. Protective effect of astragaloside IV on high glucose-induced endothelial dysfunction via inhibition of P2X7R dependent P38 MAPK signaling pathway. Oxid Med Cell Longev 2020; 2020: 1-14.
[http://dx.doi.org/10.1155/2020/5070415] [PMID: 33014270]
[3]
Yuan M, Gong M, He J, et al. IP3R1/GRP75/VDAC1 complex mediates endoplasmic reticulum stress-mitochondrial oxidative stress in diabetic atrial remodeling. Redox Biol 2022; 52: 102289.
[http://dx.doi.org/10.1016/j.redox.2022.102289] [PMID: 35344886]
[4]
Chen J, Liu Y, Pan D, et al. Estrogen inhibits endoplasmic reticulum stress and ameliorates myocardial ischemia/reperfusion injury in rats by upregulating SERCA2a. Cell Commun Signal 2022; 20(1): 38.
[http://dx.doi.org/10.1186/s12964-022-00842-2] [PMID: 35331264]
[5]
Ragni M, Ruocco C, Tedesco L, Carruba MO, Valerio A, Nisoli E. An amino acid-defined diet impairs tumour growth in mice by promoting endoplasmic reticulum stress and mTOR inhibition. Mol Metab 2022; 60: 101478.
[http://dx.doi.org/10.1016/j.molmet.2022.101478] [PMID: 35367410]
[6]
Sankrityayan H, Kale A, Gaikwad AB. Inhibition of endoplasmic reticulum stress combined with activation of angiotensin-converting enzyme 2: Novel approach for the prevention of endothelial dysfunction in type 1 diabetic rats. Can J Physiol Pharmacol 2022; 100(3): 234-9.
[http://dx.doi.org/10.1139/cjpp-2021-0170] [PMID: 34587465]
[7]
Zhou Y, Zhou C, Zhang X, Vong CT, Wang Y, Cheang WS. Coptisine attenuates diabetes-associated endothelial dysfunction through inhibition of endoplasmic reticulum stress and oxidative stress. Molecules 2021; 26(14): 4210.
[http://dx.doi.org/10.3390/molecules26144210] [PMID: 34299486]
[8]
Luo H, Lan C, Fan C, et al. Down-regulation of AMPK/PPARδ signalling promotes endoplasmic reticulum stress-induced endothelial dysfunction in adult rat offspring exposed to maternal diabetes. Cardiovasc Res 2022; 118(10): 2304-16.
[http://dx.doi.org/10.1093/cvr/cvab280] [PMID: 34415333]
[9]
Yao W, Wang K, Wang X, et al. Icariin ameliorates endothelial dysfunction in type 1 diabetic rats by suppressing ER stress via cthe PPARα/Sirt1/AMPKα pathway. J Cell Physiol 2021; 236(3): 1889-902.
[http://dx.doi.org/10.1002/jcp.29972] [PMID: 32770555]
[10]
Gurlo T, Costes S, Hoang JD, Rivera JF, Butler AE, Butler PC. βCell-specific increased expression of calpastatin prevents diabetes induced by islet amyloid polypeptide toxicity. JCI Insight 2016; 1(18): e89590.
[http://dx.doi.org/10.1172/jci.insight.89590] [PMID: 27812546]
[11]
Teng X, Ji C, Zhong H, et al. Selective deletion of endothelial cell calpain in mice reduces diabetic cardiomyopathy by improving angiogenesis. Diabetologia 2019; 62(5): 860-72.
[http://dx.doi.org/10.1007/s00125-019-4828-y] [PMID: 30778623]
[12]
Li S, Zhang L, Ni R, et al. Disruption of calpain reduces lipotoxicity-induced cardiac injury by preventing endoplasmic reticulum stress. Biochim Biophys Acta Mol Basis Dis 2016; 1862(11): 2023-33.
[http://dx.doi.org/10.1016/j.bbadis.2016.08.005] [PMID: 27523632]
[13]
Chen B, Zhao Q, Ni R, et al. Inhibition of calpain reduces oxidative stress and attenuates endothelial dysfunction in diabetes. Cardiovasc Diabetol 2014; 13(1): 88.
[http://dx.doi.org/10.1186/1475-2840-13-88] [PMID: 24886224]
[14]
Nie Q, Zhu L, Zhang L, Leng B, Wang H. Astragaloside IV protects against hyperglycemia-induced vascular endothelial dysfunction by inhibiting oxidative stress and Calpain-1 activation. Life Sci 2019; 232: 116662.
[http://dx.doi.org/10.1016/j.lfs.2019.116662] [PMID: 31323271]
[15]
Gao Y, Li L, Yu J, Zhang Z. Rosuvastatin protects PC12 cells from hypoxia/reoxygenation-induced injury by inhibiting endoplasmic reticulum stress-induced apoptosis. Exp Ther Med 2021; 22(4): 1189.
[http://dx.doi.org/10.3892/etm.2021.10623] [PMID: 34475979]
[16]
Sultan F, Kaur R, Tarfain NU, et al. Protective effect of rosuvastatin pretreatment against acute myocardial injury by regulating Nrf2, Bcl-2/Bax, iNOS, and TNF-α expressions affecting oxidative/nitrosative stress and inflammation. Hum Exp Toxicol 2022; 41
[http://dx.doi.org/10.1177/09603271211066065] [PMID: 35130744]
[17]
Boczar KE, Faller E, Zeng W, et al. Anti-inflammatory effect of rosuvastatin in patients with HIV infection: An FDG-PET pilot study. J Nucl Cardiol 2021; pp. 1-2.
[http://dx.doi.org/10.1007/s12350-021-02830-4] [PMID: 34820771]
[18]
Saadat S, Boskabady MH. Anti-inflammatory and antioxidant effects of rosuvastatin on asthmatic, hyperlipidemic, and asthmatic-hyperlipidemic rat models. Inflammation 2021; 44(6): 2279-90.
[http://dx.doi.org/10.1007/s10753-021-01499-8] [PMID: 34226988]
[19]
Birnbaum Y, Birnbaum GD, Birnbaum I, Nylander S, Ye Y. Ticagrelor and rosuvastatin have additive cardioprotective effects via adenosine. Cardiovasc Drugs Ther 2016; 30(6): 539-50.
[http://dx.doi.org/10.1007/s10557-016-6701-2] [PMID: 27830382]
[20]
Geng J, Xu H, Fu W, et al. Rosuvastatin protects against endothelial cell apoptosis in vitro and alleviates atherosclerosis in ApoE-/- mice by suppressing endoplasmic reticulum stress. Exp Ther Med 2020; 20(1): 550-60.
[http://dx.doi.org/10.3892/etm.2020.8733] [PMID: 32537013]
[21]
Legeay S, Fautrat P, Norman JB, et al. Selective deficiency in endothelial PTP1B protects from diabetes and endoplasmic reticulum stress-associated endothelial dysfunction via preventing endothelial cell apoptosis. Biomed Pharmacother 2020; 127: 110200.
[http://dx.doi.org/10.1016/j.biopha.2020.110200] [PMID: 32417688]
[22]
Osman A, El-Gamal H, Pasha M, et al. Endoplasmic reticulum (ER) stress-generated extracellular vesicles (microparticles) self-perpetuate ER stress and mediate endothelial cell dysfunction independently of cell survival. Front Cardiovasc Med 2020; 7: 584791.
[http://dx.doi.org/10.3389/fcvm.2020.584791] [PMID: 33363219]
[23]
Luo B, Li B, Wang W, et al. Rosuvastatin alleviates diabetic cardiomyopathy by inhibiting NLRP3 inflammasome and MAPK pathways in a type 2 diabetes rat model. Cardiovasc Drugs Ther 2014; 28(1): 33-43.
[http://dx.doi.org/10.1007/s10557-013-6498-1] [PMID: 24254031]
[24]
Ma YX, Li WH, Xie Q. Rosuvastatin inhibits TGF-beta1 expression and alleviates myocardial fibrosis in diabetic rats. Pharmazie 2013; 68(5): 355-8.
[PMID: 23802433]
[25]
Roan JN, Fang SY, Chang SW, et al. Rosuvastatin improves vascular function of arteriovenous fistula in a diabetic rat model. J Vasc Surg 2012; 56(5): 1381-1389.e1.
[http://dx.doi.org/10.1016/j.jvs.2012.03.243] [PMID: 22727844]
[26]
Liu J, Liu Z. muscle insulin resistance and the inflamed microvasculature: Fire from within. Int J Mol Sci 2019; 20(3): 562.
[http://dx.doi.org/10.3390/ijms20030562] [PMID: 30699907]
[27]
Cersosimo E, DeFronzo RA. Insulin resistance and endothelial dysfunction: The road map to cardiovascular diseases. Diabetes Metab Res Rev 2006; 22(6): 423-36.
[http://dx.doi.org/10.1002/dmrr.634] [PMID: 16506274]
[28]
Schwarz DS, Blower MD. The endoplasmic reticulum: Structure, function and response to cellular signaling. Cell Mol Life Sci 2016; 73(1): 79-94.
[http://dx.doi.org/10.1007/s00018-015-2052-6] [PMID: 26433683]
[29]
Zhang G, Wang X, Gillette TG, Deng Y, Wang ZV. Unfolded protein response as a therapeutic target in cardiovascular disease. Curr Top Med Chem 2019; 19(21): 1902-17.
[http://dx.doi.org/10.2174/1568026619666190521093049] [PMID: 31109279]
[30]
Zhu Q. The ER stress-autophagy axis: Implications for cognitive dysfunction in diabetes mellitus. Clin Sci (Lond) 2020; 134(11): 1255-8.
[http://dx.doi.org/10.1042/CS20200235] [PMID: 32501495]
[31]
Hosseini M, Shaygannia E, Rahmani M, et al. Endoplasmic reticulum stress (ER stress) and unfolded protein response (UPR) occur in a rat varicocele testis model. Oxid Med Cell Longev 2020; 2020: 1-11.
[http://dx.doi.org/10.1155/2020/5909306] [PMID: 32802266]
[32]
Zhou Y, Murugan DD, Khan H, Huang Y, Cheang WS. Roles and therapeutic implications of endoplasmic reticulum stress and oxidative stress in cardiovascular diseases. Antioxidants 2021; 10(8): 1167.
[http://dx.doi.org/10.3390/antiox10081167] [PMID: 34439415]
[33]
Liu C, Zhang A. ROS-mediated PERK-eIF2α-ATF4 pathway plays an important role in arsenite-induced L-02 cells apoptosis via cregulating CHOP-DR5 signaling. Environ Toxicol 2020; 35(10): 1100-13.
[http://dx.doi.org/10.1002/tox.22946] [PMID: 32506763]
[34]
Zhang X, Zhou C, Miao L, et al. Panax notoginseng protects against diabetes-associated endothelial dysfunction: Comparison between ethanolic extract and total saponin. Oxid Med Cell Longev 2021; 2021: 1-10.
[http://dx.doi.org/10.1155/2021/4722797] [PMID: 34527173]
[35]
Zhao F, Meng Y, Wang Y, et al. Protective effect of Astragaloside IV on chronic intermittent hypoxia-induced vascular endothelial dysfunction through the calpain-1/SIRT1/AMPK signaling pathway. Front Pharmacol 2022; 13: 920977.
[http://dx.doi.org/10.3389/fphar.2022.920977] [PMID: 35983375]
[36]
Han Q, Liu Q, Zhang H, et al. Simvastatin improves cardiac hypertrophy in diabetic rats by attenuation of oxidative stress and inflammation induced by calpain-1-mediated activation of nuclear factor-κB (NF-κB). Med Sci Monit 2019; 25: 1232-41.
[http://dx.doi.org/10.12659/MSM.913244] [PMID: 30767945]
[37]
Zheng D, Cao T, Zhang L, Fan G, Qiu J, Peng T. Targeted inhibition of calpain in mitochondria alleviates oxidative stress-induced myocardial injury. Acta Pharmacol Sin 2021; 42(6): 909-20.
[http://dx.doi.org/10.1038/s41401-020-00526-y] [PMID: 32968209]
[38]
Saleh DO, Mansour DF, Mostafa RE. Rosuvastatin and simvastatin attenuate cisplatin-induced cardiotoxicity via disruption of endoplasmic reticulum stress-mediated apoptotic death in rats: Targeting ER-Chaperone GRP78 and Calpain-1 pathways. Toxicol Rep 2020; 7: 1178-86.
[http://dx.doi.org/10.1016/j.toxrep.2020.08.026] [PMID: 32995293]
[39]
Lu M, Zhao F, Ran C, Xu Y, Zhang J, Wang H. Ginsenoside Rg1 attenuates diabetic vascular endothelial dysfunction by inhibiting the calpain-1/ROS/PKC-β axis. Life Sci 2023; 329: 121972.
[http://dx.doi.org/10.1016/j.lfs.2023.121972]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy